Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Cyclically Adjusted Book per Share: ¥4.90 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688336 Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
85 GF Score
Price ¥51.08
GF Value ¥67.13
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted Book per Share?

Sunshine Guojian Pharmaceutical (Shanghai) Co SHSE:688336 -5.02% 85 Cyclically Adjusted Book per Share is ¥4.90 as of Mar. 2026. GuruFocus rates SHSE:688336 with a GF Score™ of 85/100 and a GF Value™ of ¥67.13 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Sunshine Guojian Pharmaceutical (Shanghai) Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥9.618. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥4.90 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sunshine Guojian Pharmaceutical (Shanghai) Co's average Cyclically Adjusted Book Growth Rate was 17.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-16), Sunshine Guojian Pharmaceutical (Shanghai) Co's current stock price is ¥51.08. Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥4.90. Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted PB Ratio of today is 10.42.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sunshine Guojian Pharmaceutical (Shanghai) Co was 14.94. The lowest was 2.70. And the median was 4.48.


Sunshine Guojian Pharmaceutical (Shanghai) Co  (SHSE:688336) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=51.08/4.90
=10.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sunshine Guojian Pharmaceutical (Shanghai) Co was 14.94. The lowest was 2.70. And the median was 4.48.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted Book per Share Related Terms


Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted Book per Share Chart

Sunshine Guojian Pharmaceutical (Shanghai) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 3.68 4.04 4.67

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.18 4.30 4.45 4.67 4.90

SHSE:688336 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted PB Ratio falls into.


SHSE:688336
85GF Score
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd SHSE:688336
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sunshine Guojian Pharmaceutical (Shanghai) Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=9.618/116.3033*116.3033
=9.618

Current CPI (Mar. 2026) = 116.3033.

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data

Book Value per Share CPI Adj_Book
201112 1.596 92.885 1.998
201203 1.684 94.367 2.075
201206 0.000 93.495 0.000
201209 1.873 94.482 2.306
201212 1.943 95.237 2.373
201303 2.020 96.372 2.438
201306 2.131 95.984 2.582
201309 2.233 97.332 2.668
201612 3.324 102.600 3.768
201712 3.852 104.500 4.287
201812 4.354 106.500 4.755
201903 0.000 107.700 0.000
201906 4.217 107.700 4.554
201909 0.000 109.800 0.000
201912 3.566 111.200 3.730
202003 3.729 112.300 3.862
202006 3.783 110.400 3.985
202009 5.227 111.700 5.442
202012 5.040 111.500 5.257
202103 5.004 112.662 5.166
202106 5.090 111.769 5.296
202109 5.076 112.215 5.261
202112 5.083 113.108 5.227
202203 5.078 114.335 5.165
202206 5.084 114.558 5.161
202209 5.106 115.339 5.149
202212 5.150 115.116 5.203
202303 5.185 115.116 5.238
202306 5.263 114.558 5.343
202309 5.340 115.339 5.385
202312 5.475 114.781 5.548
202403 5.578 115.227 5.630
202406 5.582 114.781 5.656
202409 5.673 115.785 5.698
202412 6.225 114.893 6.301
202503 6.341 115.116 6.406
202506 6.372 114.907 6.449
202509 6.596 115.471 6.644
202512 9.452 115.832 9.490
202603 9.618 116.303 9.618

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥4.90 mean?
Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) has a Cyclically Adjusted Book per Share of ¥4.90 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Book per Share too high?
Sunshine Guojian Pharmaceutical (Shanghai) Co's current Cyclically Adjusted Book per Share is ¥4.90. Overall, Sunshine Guojian Pharmaceutical (Shanghai) Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Book per Share of ¥4.90 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. Sunshine Guojian Pharmaceutical (Shanghai) Co's current Cyclically Adjusted Book per Share is ¥4.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥67.13, compared to a current price of ¥51.08 — trading 23.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥4.90. Sunshine Guojian Pharmaceutical (Shanghai) Co's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336), the current Cyclically Adjusted Book per Share is ¥4.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Overvalued in 2026?

Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co stock appears to be undervalued. The current stock price of ¥51.08 is trading 23.9% below its estimated GF Value™ of ¥67.13. GuruFocus considers Sunshine Guojian Pharmaceutical (Shanghai) Co to be Modestly Undervalued.

Key valuation signals for SHSE:688336:

  • Cyclically Adjusted Book per Share: ¥4.90
  • GF Value™: ¥67.13 vs. price of ¥51.08 (23.9% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688336 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description

Address No.399 Libing Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
85GF Score

Get the complete analysis for SHSE:688336

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥51.08
Price
¥67.13
GF Value